Your browser doesn't support javascript.
loading
IPH4102, a first-in-class anti-KIR3DL2 monoclonal antibody, in patients with relapsed or refractory cutaneous T-cell lymphoma: an international, first-in-human, open-label, phase 1 trial.
Bagot, Martine; Porcu, Pierluigi; Marie-Cardine, Anne; Battistella, Maxime; William, Basem M; Vermeer, Maarten; Whittaker, Sean; Rotolo, Federico; Ram-Wolff, Caroline; Khodadoust, Michael S; Bensussan, Armand; Paturel, Carine; Bonnafous, Cecile; Sicard, Helene; Azim, Hatem A; Kim, Youn H.
Afiliación
  • Bagot M; Hôpital Saint Louis, Paris, France; INSERM U976, Paris 7 University, Paris, France. Electronic address: martine.bagot@aphp.fr.
  • Porcu P; Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.
  • Marie-Cardine A; INSERM U976, Paris 7 University, Paris, France.
  • Battistella M; Hôpital Saint Louis, Paris, France; INSERM U976, Paris 7 University, Paris, France.
  • William BM; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
  • Vermeer M; Leiden University Medical Center, Leiden, Netherlands.
  • Whittaker S; Guy's and St Thomas' Hospital, London, UK.
  • Rotolo F; Innate Pharma, Marseille, France.
  • Ram-Wolff C; Hôpital Saint Louis, Paris, France; INSERM U976, Paris 7 University, Paris, France.
  • Khodadoust MS; Stanford Cancer Institute, Stanford, CA, USA.
  • Bensussan A; INSERM U976, Paris 7 University, Paris, France.
  • Paturel C; Innate Pharma, Marseille, France.
  • Bonnafous C; Innate Pharma, Marseille, France.
  • Sicard H; Innate Pharma, Marseille, France.
  • Azim HA; Innate Pharma, Marseille, France.
  • Kim YH; Stanford Cancer Institute, Stanford, CA, USA.
Lancet Oncol ; 20(8): 1160-1170, 2019 08.
Article en En | MEDLINE | ID: mdl-31253572
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Linfoma Cutáneo de Células T / Receptores KIR3DL2 / Antineoplásicos Inmunológicos Tipo de estudio: Clinical_trials / Guideline Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Linfoma Cutáneo de Células T / Receptores KIR3DL2 / Antineoplásicos Inmunológicos Tipo de estudio: Clinical_trials / Guideline Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article